Related Experiment Video
Updated: Mar 17, 2026
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
Melanoma Regression and Recurrence in Zebrafish
Sonia Wojciechowska1, Zhiqiang Zeng1, James A Lister2
1Institute of Genetics and Molecular Medicine, MRC Human Genetics Unit & The University of Edinburgh Cancer Research UK Centre, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
Abstract:
Melanoma is the most lethal form of skin cancer with high mortality rates. Most melanoma cases have activating mutations in BRAF (V600E) and the selective inhibitors of BRAF(V600E) have been successfully used in patients. However, after initial tumor regression, the majority of patients develop drug resistance resulting in tumor regrowth. It is therefore important to understand the mechanisms underlying these processes. We have recently described the role of the master melanocyte transcription factor MITF in tumor growth, regression, and recurrence. Here, we describe protocols to study regression and recurrence in vivo, as well as for histology and immunohistochemistry, using a temperature-sensitive zebrafish model of human melanoma.
Insights
This study details methods for investigating melanoma drug resistance and recurrence using a zebrafish model. Understanding the role of the MITF gene in melanoma tumor regrowth is crucial for developing new treatments.
Area of Science:
- Oncology
- Genetics
- Developmental Biology
Background:
- Melanoma is an aggressive skin cancer with high mortality.
- BRAF (V600E) inhibitors are effective but often lead to drug resistance and tumor recurrence.
- The transcription factor MITF plays a key role in melanoma progression.
Purpose of the Study:
- To establish protocols for studying melanoma regression and recurrence in vivo.
- To investigate the mechanisms of drug resistance in melanoma.
- To analyze the role of MITF in melanoma tumor growth and regrowth.
Main Methods:
- Utilizing a temperature-sensitive zebrafish model of human melanoma.
- Implementing protocols for in vivo studies of tumor regression and recurrence.
- Employing histology and immunohistochemistry techniques.
Main Results:
- The study provides reproducible protocols for melanoma research.
- The zebrafish model allows for the observation of tumor dynamics.
- The role of MITF in melanoma recurrence is further elucidated.
Conclusions:
- The described protocols facilitate the study of melanoma drug resistance and recurrence.
- Understanding MITF's function is vital for overcoming treatment resistance.
- Zebrafish models offer a powerful platform for melanoma research.
More Related Videos
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
09:43Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
Published on: May 17, 2017